# Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy

> **NCT01490775** · NA · TERMINATED · sponsor: **Rex Cancer Center, Raleigh, NC** · enrollment: 27 (actual)

## Conditions studied

- Chronic Phase CML

## Interventions

- **BEHAVIORAL:** no access to eMedonline
- **BEHAVIORAL:** eMedonline access

## Key facts

- **NCT ID:** NCT01490775
- **Lead sponsor:** Rex Cancer Center, Raleigh, NC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2015-02-12
- **Final completion:** 2015-06-30
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Study was terminated due to lack of funding
- **Last updated:** 2018-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490775, "Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01490775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*